Description
BSE announces the Offer to Buy (Buyback) acquisition window schedule for Aurobindo Pharma Ltd (AUROPHARMA), open from April 23 to April 29, 2026, at an offer price of Rs. 1475 per share for up to 54,23,728 equity shares.
Summary
BSE has announced the live activities schedule for the Offer to Buy (OTB) – Acquisition Window for the buyback of shares of Aurobindo Pharma Ltd (NSE: AUROPHARMA, BSE: 524804). The buyback window is open from Thursday, 23rd April 2026 to Wednesday, 29th April 2026. The offer price is Rs. 1475.00 per share for up to 54,23,728 equity shares.
Key Points
- Security: Aurobindo Pharma Ltd | Symbol: AUROPHARMA | ISIN: INE406A01037 | Scrip Code: 524804
- Offer Size: Up to 54,23,728 equity shares
- Offer Price: Rs. 1475.00 per share
- Face Value: Rs. 1.00 | Market Lot: 1
- Bid Offering Period: 23rd April 2026 to 29th April 2026, 9:15 AM – 3:30 PM
- Give-up / Take-up: 23rd April to 28th April 2026, 9:15 AM – 3:30 PM
- Give-up (last day): 29th April 2026, 9:15 AM – 3:30 PM
- Take-up (last day): 29th April 2026, 9:15 AM – 4:00 PM
- Trading members can bid only for investors holding shares in demat form
- Investor UCC must be registered/updated with correct PAN and category in the Exchange UCC database
Regulatory Changes
No new regulatory changes introduced. This circular operationalizes an existing buyback framework under the OTB – Acquisition Window mechanism per Exchange Notices 20150930-1 and 20170203-29.
Compliance Requirements
- Trading members must ensure investor UCC is registered and updated with correct PAN number and category in the Exchange UCC database before placing bids
- Bids can only be placed for investors holding shares in demat form
- Members and custodians should note that if no securities are accepted, no End of Issue files will be generated on Extranet
- Members may access the iBBS platform and RTRMS via the designated internet or leased line URLs
- For leased line configuration, refer to Exchange Circular No. 20170503-12
Important Dates
| Event | Date | Time |
|---|---|---|
| Opening Date | Thursday, 23rd April 2026 | 9:15 AM |
| Closing Date | Wednesday, 29th April 2026 | 3:30 PM (Give-up) / 4:00 PM (Take-up) |
| Give-up / Take-up period | 23rd April – 28th April 2026 | 9:15 AM – 3:30 PM |
| Last day Give-up | 29th April 2026 | 9:15 AM – 3:30 PM |
| Last day Take-up | 29th April 2026 | 9:15 AM – 4:00 PM |
Impact Assessment
This circular is relevant to trading members, custodian members, and investors holding Aurobindo Pharma shares. The buyback at Rs. 1475 per share represents a potential exit opportunity for eligible shareholders. Participation is limited to demat holders across defined investor categories (FII, FI, MF, IC, Other QIBs, NIB, Company, Individual). Market impact is contained to the AUROPHARMA scrip during the specified window. System access details for iBBS and RTRMS are provided for operational readiness by members.
Impact Justification
Stock-specific buyback notice affecting trading members and custodians dealing in Aurobindo Pharma shares; operationally important for participants but limited to a single scrip over a defined window.